Analysis of actinomycin D treated cattle oocytes and their use for somatic cell nuclear transfer

Marcelo Tigre Moura1, Regivaldo Vieira de Sousa, Ligiane de Oliveira Leme

  • 1Laboratório de Reprodução Animal, Embrapa Recursos Genéticos e Biotecnologia, C.P. 02372 Brasília, DF, CEP 70770-900, Brazil; Departamento de Agronomia e Medicina Veterinária, Universidade de Brasília, CEP 70910-900 Brasília, DF, Brazil.

Animal Reproduction Science
|December 29, 2007
PubMed

Insights

Actinomycin D effectively inhibits cattle oocyte development and embryonic progression. However, reconstructed embryos using treated oocytes show normal apoptotic cell indices, suggesting potential for further research in assisted reproduction.

Area of Science:

  • Reproductive Biology
  • Developmental Biology
  • Cell Biology

Background:

  • Chemical enucleation is a critical step in assisted reproductive technologies.
  • Actinomycin D is a known inhibitor of transcription and replication.
  • Evaluating novel agents for oocyte manipulation is essential for improving reproductive efficiency.

Purpose of the Study:

  • To assess the efficacy of actinomycin D as a chemical enucleation agent for cattle oocytes.
  • To investigate the impact of actinomycin D on oocyte maturation, cleavage, and blastocyst development.
  • To evaluate the apoptotic status of embryos reconstructed using actinomycin D-treated oocytes.

Main Methods:

  • Cattle oocytes were matured in vitro and treated with varying concentrations and durations of actinomycin D.
  • Oocyte maturation, chromosome morphology, and embryonic development (cleavage and blastocyst rates) were assessed.
  • Somatic cell nuclear transfer (SCNT) and parthenogenetic activation were performed using treated oocytes.
  • Apoptosis was quantified using the TUNEL assay in both parthenogenetic and SCNT embryos.

Main Results:

  • Actinomycin D significantly reduced oocyte maturation, cleavage, and blastocyst rates in a dose-dependent manner.
  • Higher concentrations of actinomycin D induced chromosome uncoiling.
  • SCNT embryos derived from treated oocytes had reduced cleavage rates but improved blastocyst rates compared to the treated control.
  • Parthenogenetic embryos from treated oocytes showed increased apoptosis, while SCNT embryos had comparable apoptotic indices to controls.

Conclusions:

  • Actinomycin D demonstrates efficiency in blocking embryonic development in cattle oocytes.
  • While impacting early development, actinomycin D-treated oocytes can be used for SCNT, yielding reconstructed embryos with normal apoptotic cell profiles.
  • Further research is warranted to optimize actinomycin D application for potential use in oocyte enucleation techniques.

Related Concept Videos